By G HossainPosted on May 16, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs The star of the acquisition is the enzyme replacement therapy INZ-701, being developed for the rare disease ENPP1 deficiency. BioMarin Expands Enzyme Expertise With $270M Inozyme Buy Post navigation Lilly Makes $1.3B RNA Editing Bet With Rznomics to Build Out Hearing Loss PipelineAllogene Cuts 28% of Staff to Extend Runway, Focus on Clinical Programs